Latest Breaking News On - Gurufocus value of spero therapeutics inc - Page 1 : comparemela.com

On September 13, 2023, Chief Medical Officer Kamal Hamed sold 39,496 shares of Spero Therapeutics Inc (NASDAQ:SPRO).

Gurufocus value of spero therapeutics incSpero therapeutics incGurufocus valueSpero therapeuticsInsider tradingKamal hamedChief medical officerIopharmaceutical companyNsider transactionGurufocus value of spero therapeutics inc